AUG 12, 2026 · PHASE 3 TRIAL
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
ClinicalTrials.gov
This is a registered Phase 3 trial that has not yet begun recruitment and reports no results; the evidence base is the study design itself, not outcome data.
Reported
Planned enrollment6950
Study phasePhase 3
Primary outcome measureCV death or HHF/urgent HF visit